A citation-based method for searching scientific literature

Jessica Griffiths, Seth G N Grant. Semin Cell Dev Biol 2023
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory.
Daniela Puzzo, Lucia Privitera, Mauro Fa', Agnieszka Staniszewski, Gakuji Hashimoto, Fahad Aziz, Mikako Sakurai, Elena M Ribe, Carol M Troy, Marc Mercken,[...]. Ann Neurol 2011
218
66

Presubiculum principal cells are preserved from degeneration in knock-in APP/TAU mouse models of Alzheimer's disease.
Anam Islam, Takashi Saito, Takaomi Saido, Afia B Ali. Semin Cell Dev Biol 2023
2
50



Inhibition of Nogo-A rescues synaptic plasticity and associativity in APP/PS1 animal model of Alzheimer's disease.
Maria Vazquez Pavon, Sheeja Navakkode, Lik-Wei Wong, Sreedharan Sajikumar. Semin Cell Dev Biol 2023
2
50

Alzheimer's disease is a synaptic failure.
Dennis J Selkoe. Science 2002
33

Pinpointing the locus of GABAergic vulnerability in Alzheimer's disease.
Leire Melgosa-Ecenarro, Nazanin Doostdar, Carola I Radulescu, Johanna S Jackson, Samuel J Barnes. Semin Cell Dev Biol 2023
1
100


Revealing cell vulnerability in Alzheimer's disease by single-cell transcriptomics.
Carlos A Saura, Angel Deprada, Maria Dolores Capilla-López, Arnaldo Parra-Damas. Semin Cell Dev Biol 2023
2
50

Impairments of glutamatergic synaptic transmission in Alzheimer's disease.
Benedikt Zott, Arthur Konnerth. Semin Cell Dev Biol 2023
1
100

Early Effects of the Soluble Amyloid β25-35 Peptide in Rat Cortical Neurons: Modulation of Signal Transduction Mediated by Adenosine and Group I Metabotropic Glutamate Receptors.
Carlos Alberto Castillo, Inmaculada Ballesteros-Yáñez, David Agustín León-Navarro, José Luis Albasanz, Mairena Martín. Int J Mol Sci 2021
4
33

Amyloid β-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity.
Pin-Nan Cheng, Cong Liu, Minglei Zhao, David Eisenberg, James S Nowick. Nat Chem 2012
148
33

Sequence and structure-based peptides as potent amyloid inhibitors: A review.
Amit Mitra, Nandini Sarkar. Arch Biochem Biophys 2020
9
33

A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.
Tadamasa Arai, Daisuke Sasaki, Takushi Araya, Takeshi Sato, Youhei Sohma, Motomu Kanai. Chembiochem 2014
38
33

Determinants of potency on alpha-conotoxin MII, a peptide antagonist of neuronal nicotinic receptors.
Drew Everhart, G Edward Cartier, Arun Malhotra, Aldrin V Gomes, J Michael McIntosh, Charles W Luetje. Biochemistry 2004
48
33

Cerebrospinal fluid catecholamines in Alzheimer's disease patients with and without biological disease.
Kristi Henjum, Leiv Otto Watne, Kristin Godang, Nathalie Bodd Halaas, Rannveig Saksholm Eldholm, Kaj Blennow, Henrik Zetterberg, Ingvild Saltvedt, Jens Bollerslev, Anne Brita Knapskog. Transl Psychiatry 2022
2
50

Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes.
Jeffrey A Fein, Sophie Sokolow, Carol A Miller, Harry V Vinters, Fusheng Yang, Gregory M Cole, Karen Hoppens Gylys. Am J Pathol 2008
129
33

Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics.
Hyomin Jeong, Heewon Shin, Seungpyo Hong, YoungSoo Kim. Exp Neurobiol 2022
1
100


(Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis.
Francesca Fagiani, Cristina Lanni, Marco Racchi, Stefano Govoni. Front Mol Neurosci 2021
7
33


The costs of developing treatments for Alzheimer's disease: A retrospective exploration.
Jeffrey L Cummings, Dana P Goldman, Nicholas R Simmons-Stern, Eric Ponton. Alzheimers Dement 2022
11
33

Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
Sidhartha M Chafekar, Hinke Malda, Maarten Merkx, E W Meijer, David Viertl, Hilal A Lashuel, Frank Baas, Wiep Scheper. Chembiochem 2007
94
33

The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease.
Xingyu Zhang, Zhihui Fu, Lanxia Meng, Mingyang He, Zhentao Zhang. Front Aging Neurosci 2018
52
33


Regulation of nicotinic acetylcholine receptors in Alzheimer׳s disease: a possible role of chaperones.
Saeed Sadigh-Eteghad, Alireza Majdi, Mahnaz Talebi, Javad Mahmoudi, Shirin Babri. Eur J Pharmacol 2015
18
33


Noradrenergic mechanisms in neurodegenerative diseases: a theory.
Marc R Marien, Francis C Colpaert, Alan C Rosenquist. Brain Res Brain Res Rev 2004
300
33



Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies.
Morgan Robinson, Jennifer Lou, Banafsheh Mehrazma, Arvi Rauk, Michael Beazely, Zoya Leonenko. Int J Mol Sci 2021
5
33


Neuromodulatory Action of Picomolar Extracellular Aβ42 Oligomers on Presynaptic and Postsynaptic Mechanisms Underlying Synaptic Function and Memory.
Walter Gulisano, Marcello Melone, Cristian Ripoli, Maria Rosaria Tropea, Domenica D Li Puma, Salvatore Giunta, Sara Cocco, Daniele Marcotulli, Nicola Origlia, Agostino Palmeri,[...]. J Neurosci 2019
45
33



Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer's disease therapy.
Safura Jokar, Saeedeh Khazaei, Hossein Behnammanesh, Amir Shamloo, Mostafa Erfani, Davood Beiki, Omid Bavi. Biophys Rev 2019
27
33

Amyloid-beta aggregation.
Verena H Finder, Rudi Glockshuber. Neurodegener Dis 2007
225
33

In vitro exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat nucleus accumbens nerve terminals.
Massimo Grilli, Maria Summa, Alessia Salamone, Guendalina Olivero, Stefania Zappettini, Silvia Di Prisco, Marco Feligioni, Cesare Usai, Anna Pittaluga, Mario Marchi. Neuropharmacology 2012
31
33

Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target.
Irene L Gutiérrez, Cinzia Dello Russo, Fabiana Novellino, Javier R Caso, Borja García-Bueno, Juan C Leza, José L M Madrigal. Int J Mol Sci 2022
3
33

Aducanumab for Alzheimer disease: the amyloid hypothesis moves from bench to bedside.
Erik S Musiek, Teresa Gomez-Isla, David M Holtzman. J Clin Invest 2021
11
33

Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes.
J M Kulak, T A Nguyen, B M Olivera, J M McIntosh. J Neurosci 1997
178
33

Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.
Diego Centonze, Luca Muzio, Silvia Rossi, Francesca Cavasinni, Valentina De Chiara, Alessandra Bergami, Alessandra Musella, Marcello D'Amelio, Virve Cavallucci, Alessandro Martorana,[...]. J Neurosci 2009
277
33

The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology.
M L Giuffrida, F Caraci, P De Bona, G Pappalardo, F Nicoletti, E Rizzarelli, A Copani. Rev Neurosci 2010
64
33

Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens.
Stefania Preda, Stefano Govoni, Cristina Lanni, Marco Racchi, Elisa Mura, Massimo Grilli, Mario Marchi. Neuropsychopharmacology 2008
40
33

Expression, purification and use of recombinant annexin V for the detection of apoptotic cells.
Susan E Logue, Mohamed Elgendy, Seamus J Martin. Nat Protoc 2009
118
33



Dual effect of beta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus.
Elisa Mura, Stefania Zappettini, Stefania Preda, Fabrizio Biundo, Cristina Lanni, Massimo Grilli, Anna Cavallero, Guendalina Olivero, Alessia Salamone, Stefano Govoni,[...]. PLoS One 2012
54
33

Allosteric modulation of nicotinic acetylcholine receptors.
Anna Chatzidaki, Neil S Millar. Biochem Pharmacol 2015
62
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.